Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens
- PMID: 1097573
- PMCID: PMC2189884
- DOI: 10.1084/jem.142.1.165
Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens
Abstract
The data presented in this paper establish the finding that multiple specific protective antibodies exist in rabbits in response to immunization with Group B streptococci. The summary in Table I indicates the serological types into which Group B streptococci have been divided on the basis of their antigenic composition. This classification is dependent upon passive protection of mice with antibodies directed against the specific antigens, and types are defined in these terms. Heretofore, it was thought that type-specific polysaccharides accounted for all such protection in Group B streptococci. Certain exceptions of cross-protection between types due to minor polysaccharide determinants soon appeared; cross-protection reactions based on protein determinants in at least two types were also discovered. The present experiments show that specific antibodies directed to either polysaccharide or protein antigens of a single strain can be protective against infection with streptococci containing these antigens.
Similar articles
-
Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens.Vaccine. 2010 Oct 8;28(43):6997-7008. doi: 10.1016/j.vaccine.2010.08.041. Epub 2010 Aug 21. Vaccine. 2010. PMID: 20732466
-
Mouse-protective antibodies against the Ibc proteins of group B streptococci.Acta Pathol Microbiol Immunol Scand B. 1985 Apr;93(2):121-4. doi: 10.1111/j.1699-0463.1985.tb02862.x. Acta Pathol Microbiol Immunol Scand B. 1985. PMID: 3893032
-
[Serologic cross reactions of group B streptococci].Immun Infekt. 1985 Nov;13(6):276-82. Immun Infekt. 1985. PMID: 2416673 German.
-
Immunochemical characterization of the polysaccharide antigens of group B streptococci.Rev Infect Dis. 1988 Jul-Aug;10 Suppl 2:S367-71. doi: 10.1093/cid/10.supplement_2.s367. Rev Infect Dis. 1988. PMID: 3142018 Review.
-
Pseudomonas aeruginosa antigens as potential vaccines.FEMS Microbiol Rev. 1997 Nov;21(3):243-77. doi: 10.1111/j.1574-6976.1997.tb00353.x. FEMS Microbiol Rev. 1997. PMID: 9451816 Review.
Cited by
-
Antibody-independent and -dependent opsonization of group B Streptococcus requires the first component of complement C1.Infect Immun. 1985 Jul;49(1):19-24. doi: 10.1128/iai.49.1.19-24.1985. Infect Immun. 1985. PMID: 3891622 Free PMC article.
-
Opsonic effect of jacalin and human immunoglobulin A on type II group B streptococci.Infect Immun. 1990 Nov;58(11):3663-70. doi: 10.1128/iai.58.11.3663-3670.1990. Infect Immun. 1990. PMID: 2228238 Free PMC article.
-
Detection of group B streptococcal antibodies in human sera by radioimmunoassay: concentrations of type-specific antibodies in sera of adults and infants infected with group B streptococci.J Clin Microbiol. 1978 Feb;7(2):194-201. doi: 10.1128/jcm.7.2.194-201.1978. J Clin Microbiol. 1978. PMID: 344339 Free PMC article.
-
Immunity to the group B streptococci: interaction of serum and macrophages with types Ia, Ib, and Ic.J Exp Med. 1976 May 1;143(5):1186-98. doi: 10.1084/jem.143.5.1186. J Exp Med. 1976. PMID: 772153 Free PMC article.
-
Estimation of invasive Group B Streptococcus disease risk in young infants from case-control serological studies.BMC Med Res Methodol. 2022 Mar 27;22(1):85. doi: 10.1186/s12874-022-01529-5. BMC Med Res Methodol. 2022. PMID: 35350991 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources